Proceedings of the Twelfth Annual UT-ORNL-KBRIN Bioinformatics Summit 2013 by Eric C Rouchka & Robert M Flight
INTRODUCTION Open Access
Proceedings of the Twelfth Annual UT-ORNL-KBRIN
Bioinformatics Summit 2013
Eric C Rouchka1*, Robert M Flight2
From 12th Annual UT-ORNL-KBRIN Bioinformatics Summit 2013
Buchanan, TN, USA. 22-24 March 2013
The University of Tennessee (UT), the Oak Ridge National
Laboratory (ORNL), and the Kentucky Biomedical
Research Infrastructure Network (KBRIN), have collabo-
rated over the past twelve years to share research and
educational expertise in bioinformatics. One result of this
collaboration is the joint sponsorship of an annual regional
summit to bring together researchers, educators and stu-
dents who are interested in bioinformatics from a variety
of research and educational institutions. This summit pro-
vides unique opportunities for collaboration and forging
links between members of the various institutions. This
year, the Twelfth Annual UT-ORNL-KBRIN Bioinfor-
matics Summit was held at Paris Landing State Park in
Buchanan, TN from March 22-24, 2013. A total of 182
participants pre-registered for the summit, with 116 from
various Tennessee institutions and 54 from various
Kentucky institutions. A number of additional participants
came from universities and research institutions from
other states and countries, e.g. University of British
Columbia, University of Arkansas Medical Sciences,
Michigan State University, University of Cincinnati, Iowa
State University, etc. Sixty-six registrants were faculty,
with an additional 46 students, 43 staff, and 92 postdoc-
toral participants.
The conference program consisted of three days of
presentations. The first afternoon consisted of two work-
shops, one for Next-Generation Sequence Analysis, and
a second on analysis of data resulting from the Conditions
Affecting Neurocognitive Development and Learning in
Early childhood (CANDLE) project. The remainder was
dedicated to scientific presentations divided into three
plenary sessions on Next-Generation Sequencing, Transla-
tional Bioinformatics, and Systems Biology. In addition,
ten short talks were selected from 43 submitted poster
abstracts.
Friday workshops
Ramin Homayouni (University of Memphis) and
Zhongming Zhao (Vanderbilt University) opened the
Bioinformatics Summit with a workshop titled “Tools
and Applications for Next Gen Sequencing.” Michael
Dickens from the University of Memphis began the
workshop with an overview of bioinformatics tools used
in the assembly and annotation of de novo genomes.
This presentation covered various tools involved in the
pipeline aspects of sequencing and quality control, de
novo assembly, genome annotation, and manual annota-
tion. This included a discussion of WebApollo [http://
genomearchitect.org], a web-based community annota-
tion integrated with JBrowse [1]. Pelin Jia from Vander-
bilt University followed with a discussion of a pipeline
for variant calling within NGS data. She discussed var-
ious aspects of the pipeline, including quality control
using FastQC [http://www.bioinformatics.babraham.ac.
uk/projects/fastqc/]; sequence mapping; post-processing
in terms of alignment, marking duplicates, realignment,
and base recalibration; variant calling; variant filtering;
and variant annotation.
The second half of the opening workshop consisted of
workshops on two NGS tools. The first of these tools was
MuTect [2] discussed by Huy Vuong from Vanderbilt
University. MuTect is a tool used for detection of somatic
mutations in cancer which incorporates information from
the Catalog of Somatic Mutations in Cancer (COSMIC)
[3] as well as tools for calling single nucleotide variants
(SNVs). The second tool covered by Qingguo Wang was
VirusFinder [4], a tool for detecting viruses and their inte-
gration sites using next-generation sequencing data.
Celeste Luketic from Life Technologies closed the first
workshop with a discussion of the Ion TorrentTM PGMTM
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and ProtonTM sequencers. These sequencers are based on
a semiconductor platform that detects nucleotide incor-
poration by measuring the resultant change in pH [5]. In
addition to discussing the technology and the associated
software, Celeste discussed applications using Ion based
technologies, including the Ion AmpliSeqTM panels. These
ready-to-use panels contain a set of targeted regions
for specific diseases, including the cancer hotspot panel,
comprehensive cancer panel, inherited disease panel, and
sample ID panel for SNP genotyping.
The second workshop of the afternoon focused on
“Availability and Uses of CANDLE Genomic Data.” Fran
Tylavsky from the University of Tennessee Health
Science Center (UTHSC) kicked off the second workshop
by giving an overview of a project studying the conditions
affecting neurocognitive development and learning in
early childhood (CANDLE) [6]. This project, which
involves a total of 1474 children (1404 which are active),
collected various data using 54 instruments at 24 differ-
ent time-points, resulting in over 14 million pieces of
data, including approximately 900,000 sequence variants
at 27,000 sites. Building upon the vast amount of data
available through CANDLE, Beni Mozhui from UTHSC
followed with a discussion of multiscalar analysis
of CANDLE using GeneNetwork [7] and PLINK [8].
GeneNetwork is a platform designed to facilitate genetic
studies and integrative systems genetics and models
through data storage and data analysis while PLINK is a
toolset allowing for whole-genome association and popu-
lation-based linkage analyses. Rob Williams (UTHSC)
closed the second workshop with a hands on demonstra-
tion of GeneNetwork functionality by applying it to the
CANDLE dataset.
Session I: next generation sequencing
Jinghui Zhang (St. Jude’s Children’s Research Hospital)
began the formal program with a talk titled “Analysis of
next-generation sequencing data for pediatric cancer gen-
omes: discoveries, challenges and lessons learned.” In this
presentation, Dr. Zhang presented a summary of discov-
eries resulting from the Pediatric Cancer Genome Project
(PCGP), a $65 Million collaboration between St. Jude’s
and Washington University in St. Louis [9]. As part of this
project, paired next generation sequencing is being per-
formed at the whole genome for both tumor and normal
cells for each of 600 pediatric cancer patients. Dr. Zhang
discussed a number of interesting discoveries, as well as
the development of tools for understanding structural
variations in cancer, such as CREST [10].
Tony Capra (Vanderbilt University) followed with a talk
titled “Integrating genome-scale data to predict the effect
of human-specific non-coding mutations.” Dr. Capra pre-
sented a summary of the evolutionary analysis between
humans and our closest relatives, chimpanzees. Whole
genome sequencing of the chimp genome [11] shows that
humans and chimps share a 99% similarity in non-coding
regions, with nearly identical protein coding sequences.
However, a number of regions have been found where the
sequence is much more divergent in humans than
between chimpanzees and other distantly related species.
These regions, called human accelerated regions (HARs)
[12,13] were further studied. A total of 728 HARs are
found across the human genome, with 69% in intergenic
regions, 21% in introns, 6% in UTRs, and 4% in protein
coding regions [14]. HARs tend to be enriched near tran-
scription factors, developmental genes, and genes impli-
cated in diseases. The thought is that these regions
function as transcriptional enhancers. Dr. Capra and his
group have been working on developing machine learning
approaches for detecting possible roles as tissue-specific
enhancers of the HARs, and experimentally validating the
results.
Session II: translational bioinformatics
Saturday morning began with a presentation titled
“Channotyping Epilepsy – Complexity in Ion Channel
Gene Profiles and Personal Risk Prediction”, by Dr. Tara
Klassen (Baylor College of Medicine). Dr. Klassen opened
the talk by taking the vantage point that perhaps ion
channels are the best markers for disease. Over 40
genetic disorders, or channelopathies, caused by ion
channels have been characterized, including spinocere-
bellar ataxia type 13 [15], long and short QT syndrome
[16], cystic fibrosis [17], retinitis pigmentosa [18], and
several forms of epilepsy. Epilepsy is a spectrum of disor-
ders, affecting 2.2 million people in the United States and
65 Million worldwide [19]. Since the same ion channel
gene can cause different excitability disorders in different
tissues, a cohort was studied at the Baylor College of
Medicine hospitals, including 152 patients with idiopathic
epilepsy and 139 with neurologically normal controls.
A total of 237 ion channel genes were sequenced and
analyzed [20]. From the exploration of the SNPs in these
ion channels, it was observed that rare severe ion channel
SNPs do not predict epilepsy. In fact, individuals, both
with and without epilepsy, can carry multiple mutations in
human epilepsy (hEP) genes. Dr. Klassen discussed that it
was more of a complex combination of SNPs within hEP
genes, and that a systems approach combining sequencing,
transcriptomics, proteomics, and modelling was the best
approach to understanding the role of ion channel SNPs
in epilepsy.
Following Dr. Klassen’s talk was a presentation by
Stephen Wong (Weill Cornell Medical College) on “Sys-
tems and Chemical Biology Strategies for Drug Reposition-
ing.” In this talk, Dr. Wang discussed approaches to
repositioning old drugs, given that the current cost to bring
a drug to market costs $1 billion and takes 15 years [21].
Rouchka and Flight BMC Bioinformatics 2013, 14(Suppl 17):A1
http://www.biomedcentral.com/1471-2105/14/S17/A1
Page 2 of 4
Due to this prohibitive cost, the pharmaceutical industry
has moved to drug repurposing, resulting in over 40 repo-
sitioned drugs [22]. Using computational methodologies,
Dr. Wang proposed using knowledge-based, network-
based, and disease similarity-based methodologies to aid
in drug repositioning. The result is DrugMap Central,
which provides an integrative view of multi-dimensional
drug data, including basic chemical information, targets,
target-related signalling pathways, clinical trial informa-
tion, and FDA approval information [23].
Session III: systems biology
Joerg Gsponer (University of British Columbia) began the
Sunday sessions with a talk titled “New insights into neu-
rodegeneration by computational approaches.” In this pre-
sentation, Dr. Gsponer discussed the role that intrinsically
unstructured proteins (IUPs) play in neurodgeneration.
Up to one-third of all proteins contain large IUP regions
that lack a unique structure [24]. In addition to their lack
of higher order structure, many IUPs are also found to
form protein aggregates [25]. Cellular systems balance the
detrimental and beneficial effect of protein aggregation.
IUPs are typically found in low abundance and are short
lived. A number of IUPs have been shown to have roles in
neurodegenerative diseases such as Alzheimer’s and
Parkinson’s diseases. Dr. Gsponer discussed computational
approaches to understanding the regulation of aggregation
prone proteins, based on the complexity of the 5’ untrans-
lated region (UTR). The 5’ UTR of IUPs typically contains
RNA binding motifs, with one example being KHD1
which binds two-thirds of all poly-Q/N proteins [26].
Dr. Gsponer discussed the NeuroGeM Knowledgebase
[http://www.chibi.ubc.ca/neurogem/] which contains 1,218
modifiers from 8 disease models, including Alzheimer’s,
Huntington’s, poly-q, Parkinson’s, Spinocerebellar ataxia,
and amyotrophic lateral sclerosis. He discussed Meta-
analysis techniques his group is employing to integrate
functional enrichment, disease-specific modifiers, and
highly interconnected modifiers to predict modifiers of
IUPs for further experimental validation.
Paul Pavlidis (University of British Columbia) closed out
the invited speaker portion of the 2013 Summit with a
presentation “From gene lists, networks and annotations
to function.” The purpose of the presented work was to
present the lack of available resources for linking together
the genetic basis for diseases and phenotypes. Dr. Pavlidis
described Neurocarta, a knowledgebase containing 7,000
genes and 2,000 phenotypes along with supporting evi-
dence linking the genes and phenotypes [27]. Neurocarta
was initially developed as a neuroscience resource, and
therefore has detailed information about neurodevelop-
mental disorders. In addition, Dr. Pavlidis discussed issues
with annotation resources, pointing to biases and redun-
dancy in Gene Ontology annotations [28] along with the
incorrect assumption of “guilt by association” genes which
assumes that interacting genes are likely to share similar
functions [29,30].
Posters and short talks
The poster session was held on day two. Forty-three pos-
ters were on display, from a variety of different research
areas. A number of posters were also selected for short
talks. These included “Making data accessible to biologists:
small group assignment of correlated genes” (Antony
Athippozhy, University of Kentucky); “Giving raw data a
chance to talk: a demonstration of de-identified Pediatric
Research Database (PRD) and exploratory analysis techni-
ques for possible research cohort discovery and identifi-
able high risk factors for readmission” (Teeradache
Viangteeravat, Children’s Foundation Research Institute);
“Power and sample size of two-stage extreme phenotype
sequencing design for next generation sequencing studies”
(Guolian Kang; St. Jude’s Children’s Research Hospital),
“Diffsplice: the genome-wide detection of differential
splicing events with RNA-seq” (Yin Hu, University of
Kentucky); “A client-oriented workshop on the essentials
of next gen sequencing data acquisition and bioinformatics
analysis” (Pat Calie, Eastern Kentucky University); “Gene
networks in the Phytophthora capsisci/Solanum lycopersi-
cum pathosystem” (Jordan Bird, University of Tennessee –
Knoxville); “Our strategy to achieve and document
reproducible computing” (Nisrine Enyinda, St. Jude’s
Children’s Research Hospital); “Isoform reconstruction
through molecule inference with statistical isoform selec-
tion” (Yan Huang, University of Kentucky); “Using par-
tially ordered sets to represent and predict true patterns of
gene response to treatments” (Nam Vo, University of
Memphis); and “Query based sampling and multi-layered
semantic analysis to find robust network of associa-
tion between drugs and disease” (Karthikka Ramani
Muthukuri, University of Memphis). For full author lists
and abstracts see the rest of the supplement.
Future plans
The 2014 Bioinformatics summit will return to the state of
Kentucky and is scheduled for April 11-13, 2014 at Lake
Barkley State Park. Potential focus areas include current
technological trends in molecular biology, applications of
next-generation sequencing, and systems biology.
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